16D0 Kim, Lyndon J. - Thomas Jefferson University - Thomas Jefferson University
Dr. Kim

Lyndon J. Kim, MD

Contact Dr. Kim

900 Walnut Street
Suite 200
Philadelphia, PA 19107

(215) 955-7000

Most Recent Peer-reviewed Publications

  1. A phase 2 trial of verubulin for recurrent glioblastoma: A prospective study by the brain tumor investigational consortium (BTIC)
  2. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme
  3. The potential role of magnetic resonance spectroscopy in image-guided radiotherapy
  4. Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience
  5. Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: Prognosis and identification by 111indium-octreotide imaging
  6. Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas
  7. A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
  8. Primary brain tumors: Characteristics, practical diagnostic and treatment approaches
  9. A phase I trial of enzastaurin in patients with recurrent gliomas
  10. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
  11. Erratum: Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme (Journal of Neuro-Oncology (2008) vol. 89 (339-357) 10.1007/s11060-008-9615-4)
  12. Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme
  13. A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors
  14. Chemotherapeutic options for primary brain tumors
  15. Neoplastic meningitis.
  16. Lipid-associated sialoprotein in the cerebrospinal fluid: Association with brain malignancies
  17. White-matter abnormalities in unirradiated patients cured of primary central nervous system lymphoma
  18. Concurrent chemotherapy and radiotherapy in patients with brain tumors
  19. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors
  20. Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants
0